This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: The Salk Institute, Other. Active years: 1992-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1992-2007
Title: The Innovative Contributions of Henry M. Sucov
Introduction
Henry M. Sucov is an accomplished inventor based in San Diego, California. With a remarkable portfolio, he holds four patents that showcase his significant contributions to the field of biomedicine. His work primarily focuses on the innovative characterization of DNA segments that play a crucial role in transcriptional activation and repression.
Latest Patents
One of Henry M. Sucov's latest patents involves the discovery and characterization of response element compositions specifically designed for various receptors in the steroid/thyroid superfamily. This groundbreaking work enables the development of transcriptional control regions that, when combined with functional promoters, can lead to the creation of recombinant DNA vectors. These vectors can control gene transcription in response to specific ligands, enhancing the precision of gene expression modulation in cellular environments.
Career Highlights
Throughout his career, Henry M. Sucov has made significant strides in biological research, particularly while affiliated with the Salk Institute for Biological Studies. His research contributions have advanced the understanding of genetic expression and its applications in therapeutic contexts.
Collaborations
Henry has had the opportunity to collaborate with notable figures in the scientific community, including Ronald Mark Evans and Kazuhiko Umesono. Their collaborative efforts have likely further enriched the research landscape and led to advancements in their shared fields of study.
Conclusion
Henry M. Sucov's innovative spirit and dedication to research continue to inspire advancements in the realms of genetics and biotechnology. His patents not only reflect his expertise but also contribute to the ongoing evolution of gene therapy and recombinant DNA technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile